In the second quarter of 2025, U.S. equity markets rebounded notably following a challenging first quarter. Read more here.

Phase 2/3 Wave II Clinical Study to Begin in 2026 Completion of Financing to Support Registration Program MONTREAL, Sept. CNW ...